The title compound, 5-hydroxy-4-methyl-5,6-di-pyridin-2-yl-4,5-dihydro-2H-[1,2,4]triazine-3-thione (C₁₄H₁₃N₅OS), was prepared and characterized by electronic spectroscopy and single-crystal X-ray diffraction (XRD). The compound crystallizes in the triclinic space group P-1 with a = 9.0126(7) Å, b = 9.0126(7) Å, c = 9.5199(8) Å, α = 85.031(7)°, β = 77.015(7)° and γ = 67.983(6)°. In addition to the molecular geometry, vibrational frequencies and gauge-including atomic orbital (GIAO) ¹H and ¹³C NMR chemical shift values of the title compound in the ground state have been calculated using the Hartree–Fock (HF) and density functional theory (DFT) methods with 6-31G(d) basis sets, and compared with the experimental data. The calculated results show that the optimized geometries can well reproduce the crystal structural parameters and the theoretical vibrational frequencies, and ¹H and ¹³C NMR chemical shift values show good agreement with experimental data. To determine conformational flexibility, the molecular energy profile of the title compound was obtained by semi-empirical (AM1) calculations with respect to the selected torsion angle, which was varied from −180° to +180° in steps of 10°. The energetic behaviour of the title compound in solvent media was examined using the B3LYP method with the 6-31G(d) basis set by applying the Onsager and the Polarizable Continuum Model (PCM). The results obtained with these methods reveal that the PCM method provided more stable structure than Qnsager’s method. By using TD-DFT method, electronic absorption spectra of the title compound have been predicted and a good agreement with the TD-DFT method and the experimental one is determined. The predicted non-linear optical properties of the title compound are much greater than ones of urea. In addition, the molecular electrostatic potential (MEP), frontier molecular orbitals (FMO) analysis and thermodynamic properties of the title compound were investigated using theoretical calculations.

In this study, we investigated the antifungal activity of four different chitosan against Sclerotinia sclerotiorum and Fusarium oxysporum f.sp. cucumerinum (FOC). In addition, molecular docking studies of the chitosan compound against plant pathogens have been evaluated. Concentrations of 0.2, 0.3, 0.5, 1 and 2 mg/mL of each chitosan were used. The activity rate increased as the amount of concentration increased. Strong antifungal effects were observed at concentrations of 1 and 2 mg/mL of chitosan used against test fungi. For the first time with this study, the activity of chitosan against F. oxysporum f. sp. cucumerinum and molecular docking studies against both test pathogens were determined.